A patient presents to the emergency department with vomiting, diarrhea, lacrimation, abdominal cramps, and piloerection. The family members report a history of substance use for the past month. The clinical presentation is due to what?
All of the following are actions produced by mu receptors of morphine except:-
A female was given morphine sulphate during labour for pain but she developed respiratory distress. Which of the following will be the correct antidote?
True about epidural opioid are all except:
What is the action of buprenorphine at the mu-opioid receptor?
Which of the following drugs is used in opioid maintenance therapy?
Which drug is commonly used for outpatient department (OPD) analgesia?
CAGE questionnaire is used in:
ADHD in childhood can lead to which of the following in the future?
A patient with bronchial asthma develops osteoporosis. Most likely mechanism?
Explanation: ***Opioid withdrawal*** - The constellation of **vomiting, diarrhea, lacrimation, abdominal cramps, and piloerection** (gooseflesh) are classic signs and symptoms of **opioid withdrawal**. - These symptoms reflect a **hyperactive sympathetic nervous system** as the body attempts to compensate for the absence of exogenous opioids. *Cocaine intoxication* - Cocaine intoxication typically presents with **euphoria, hyperactivity, tachycardia, hypertension, and paranoia**, which are not seen here. - It is characterized by **sympathomimetic effects**, leading to an agitated and stimulated state, rather than the distress seen in withdrawal. *Cocaine withdrawal* - Cocaine withdrawal typically manifests as **dysphoria, fatigue, increased appetite, psychomotor retardation or agitation, and vivid unpleasant dreams**, not the GI and autonomic symptoms described. - The primary symptoms are psychological and energetic, often described as a "crash" rather than the physical distress of opioid withdrawal. *Opioid intoxication* - Opioid intoxication primarily causes **CNS depression**, including **respiratory depression, meiosis (pinpoint pupils), sedation, and constipation**. - The patient's symptoms of vomiting, diarrhea, and lacrimation are contrary to the effects of opioid intoxication.
Explanation: ***Hyperalgesia***- **Hyperalgesia** is not a direct effect of **μ-opioid receptor activation**; in fact, μ-receptor activation causes **analgesia**.- While chronic opioid use can lead to **opioid-induced hyperalgesia**, this is a complex phenomenon involving adaptations to long-term exposure, not an acute action of the receptor itself.*Respiratory depression*- Activation of **μ-opioid receptors** in the **brainstem** leads to a dose-dependent decrease in respiratory rate and depth [1].- This effect is mediated by reduced sensitivity of respiratory centers to **CO2 levels**, making it a major concern in opioid overdose [1].*Miosis*- **Miosis** (pinpoint pupils) is a classic sign of **opioid intoxication** and results from excitatory actions of μ-opioid receptor activation on the **Edinger-Westphal nucleus** of the oculomotor nerve [1, 3].- This effect is mediated through inhibition of **GABAergic neurons**, leading to increased parasympathetic outflow to the iris sphincter.*Decreased GI motility*- Activation of **μ-opioid receptors** in the **gastrointestinal tract** reduces peristalsis, increases water reabsorption, and decreases secretions [1, 2].- This leads to **constipation**, a very common and persistent side effect of opioid use [1, 2].
Explanation: ***Naloxone*** - **Naloxone** is a pure opioid antagonist that rapidly reverses the effects of **opioid overdose** [1, 3], including **respiratory depression** [2], by competitively binding to opioid receptors [1]. - Its short half-life may necessitate repeated doses, especially with longer-acting opioids like morphine, to prevent recurrence of respiratory depression [1]. *Epinephrine* - **Epinephrine** is an adrenergic agonist used to treat **anaphylaxis** and severe allergic reactions, as it causes **vasoconstriction** and **bronchodilation**. - It is not an antidote for opioid-induced respiratory depression, which primarily results from central nervous system effects rather than allergic reactions. *Pralidoxime* - **Pralidoxime** is a **cholinesterase reactivator** used to treat poisoning by **organophosphates**, which inhibit acetylcholinesterase, leading to cholinergic crisis. - It works by restoring the function of the enzyme, thereby breaking down excess acetylcholine, and is not indicated for opioid overdose. *Atropine* - **Atropine** is an **anticholinergic agent** that blocks muscarinic acetylcholine receptors, used to treat **bradycardia** and **organophosphate poisoning**. - It would not reverse opioid-induced respiratory depression, as it primarily affects the parasympathetic nervous system and does not antagonize opioid receptor effects.
Explanation: **Function of the intestine is not affected** - **Epidural opioids** can indeed cause **constipation** and other gastrointestinal side effects by affecting opioid receptors in the **gut wall**, thus disturbing normal intestinal motility. - The phrase "not affected" is incorrect because **opioids inherently reduce gastrointestinal motility**, leading to common side effects such as nausea, vomiting, and constipation. *Act on dorsal horn substantia gelatinosa* - This statement is true; **epidural opioids work primarily by binding to opioid receptors** in the **substantia gelatinosa** of the dorsal horn of the spinal cord. - This binding **inhibits the release of neurotransmitters** like substance P, thus preventing the transmission of pain signals. *Can cause Itching* - **Pruritus (itching)** is a very common side effect of **epidural opioids**, often concentrated around the face and trunk. - It results from the **activation of opioid receptors** in the central nervous system and the release of histamine. *Can cause respiratory depression* - **Respiratory depression** is a serious and potentially life-threatening side effect of **epidural opioids**, particularly with higher doses or systemic absorption. - It occurs due to the **suppression of the medullary respiratory centers** in the brainstem.
Explanation: ***Partial agonist*** - Buprenorphine binds to the **mu-opioid receptor** but produces a **submaximal effect** compared to full agonists. - This property contributes to its **lower abuse potential** and a ceiling effect for respiratory depression. *Partial antagonist* - This term is generally not used in pharmacology; however, a partial antagonist would imply binding to a receptor and producing a partial block of agonist activity, which is not the primary action of buprenorphine. - Buprenorphine can act as an antagonist in the context of strong full agonists, but its primary action at the mu-opioid receptor is agonism. *Complete agonist* - A complete agonist, like **morphine**, would produce the **maximal possible effect** at the receptor. - Buprenorphine's effects plateau, even with increasing doses, indicating it is not a complete agonist. *Complete antagonist* - A complete antagonist, such as **naloxone**, binds to the receptor but **produces no intrinsic activity** and blocks the effects of agonists. - Buprenorphine does produce intrinsic activity (analgesia), so it is not a complete antagonist.
Explanation: ***Buprenorphine*** - **Buprenorphine** is a **partial opioid agonist** used in opioid maintenance therapy to reduce cravings and withdrawal symptoms without producing the full euphoric effects of other opioids. - It is often combined with **naloxone** (as Suboxone) to prevent misuse by injection, as naloxone is only active if injected. - Buprenorphine has a **ceiling effect** for respiratory depression, making it safer than full agonists like methadone. *Naltrexone* - **Naltrexone** is an **opioid antagonist** that blocks opioid receptors, preventing the euphoric effects of opioids and reducing cravings. - While used in opioid use disorder treatment, it is primarily for relapse prevention and not typically for the active maintenance phase where agonist effects are desired. *Clonidine* - **Clonidine** is an **alpha-2 adrenergic agonist** primarily used to manage the **autonomic symptoms of opioid withdrawal**, such as anxiety, sweating, and rapid heart rate. - It does not directly act on opioid receptors and is not a primary agent for long-term opioid maintenance therapy. *Disulfiram* - **Disulfiram** is a drug used in the treatment of **alcohol use disorder**, not opioid use disorder. - It works by inhibiting acetaldehyde dehydrogenase, leading to an unpleasant reaction when alcohol is consumed. *Naloxone* - **Naloxone** is an **opioid antagonist** used for **emergency reversal of opioid overdose**, not for maintenance therapy. - It rapidly displaces opioids from receptors and reverses respiratory depression. - While combined with buprenorphine in Suboxone to prevent misuse, naloxone itself is not used for maintenance therapy.
Explanation: ***Paracetamol*** - It is a widely used and generally **safe analgesic** and antipyretic often prescribed for mild to moderate pain in an outpatient setting. - Its favorable side effect profile and availability as an **over-the-counter (OTC)** medication make it a first-choice drug for many common pain conditions. *Diclofenac* - While it is an effective NSAID used for pain and inflammation, its use can be associated with **gastrointestinal side effects** like ulcers and bleeding, as well as cardiovascular risks. - It is often reserved for more significant inflammatory pain or when other analgesics are insufficient, and may require more careful monitoring in an outpatient setting. *Ibuprofen* - Similar to diclofenac, Ibuprofen is an **NSAID** which is effective for pain and inflammation. However, it also carries risks of **gastrointestinal irritation** and renal side effects, especially with prolonged use or in certain patient populations. - While available OTC, its use for routine outpatient analgesia may be less preferred than paracetamol in some cases due to its GI and renal side effect profile. *Tramadol* - Tramadol is a **central acting opioid analgesic** with a higher potential for side effects such as nausea, dizziness, constipation, and the risk of dependence or abuse. - It is typically reserved for moderate to severe pain that is not adequately managed by non-opioid analgesics, and its prescription often involves more stringent monitoring than paracetamol.
Explanation: ***Alcohol dependence*** - The **CAGE questionnaire** is a widely used screening tool for identifying potential **alcohol problems** and dependence. - The acronym CAGE stands for Cutting down, Annoyance by criticism, Guilty feelings, and Eye-openers, all related to drinking habits. *Opiate poisoning* - Screening for opiate use or poisoning typically involves asking about **drug use history**, conducting **urine drug screens**, and observing specific clinical signs like **pinpoint pupils** and **respiratory depression**. - The CAGE questionnaire is not designed to screen for opiate use. *Dhatura poisoning* - **Dhatura poisoning** is characterized by anticholinergic symptoms like **dilated pupils**, **dry mouth**, **tachycardia**, and **delirium**. - Diagnosis relies on clinical presentation and a history of exposure, not a specific questionnaire like CAGE. *Barbiturate poisoning* - **Barbiturate poisoning** presents with central nervous system depression, including **sedation**, **respiratory depression**, and **hypotension**. - Diagnosis involves a clinical assessment, history of barbiturate use, and toxicology screens, not the CAGE questionnaire.
Explanation: ***All of the options*** - Childhood ADHD is associated with an increased risk of developing various long-term negative outcomes, including **substance use disorders** (like alcoholism), **antisocial behaviors**, and impacts on **academic and occupational functioning** which can be broadly termed intellectual or cognitive impacts. - The inattentiveness, impulsivity, and hyperactivity characteristic of ADHD can disrupt normal development, leading to difficulties in social interactions, educational attainment, and emotional regulation, all contributing to these wider issues. *Intellectual changes* - While ADHD does not directly cause an intellectual disability, it can significantly impact **academic performance**, executive function, and the ability to apply learned knowledge, leading to what might be perceived as intellectual challenges or underachievement. - Difficulties with sustained attention, organization, and impulse control can hinder learning processes and the acquisition of new skills, influencing cognitive development and application. *Alcoholism* - Individuals with ADHD, particularly those with untreated or poorly managed symptoms, have a significantly **higher risk of developing substance use disorders**, including alcoholism. - The impulsive nature and difficulty with self-regulation often seen in ADHD can contribute to engaging in risky behaviors, including substance experimentation and dependence, as a form of self-medication or coping mechanism. *Antisocial behaviour* - ADHD, especially when comorbid with **oppositional defiant disorder (ODD)** or **conduct disorder (CD)**, is a significant risk factor for the development of antisocial behaviors and later antisocial personality disorder. - Impulsivity, poor emotional regulation, and difficulties understanding consequences can predispose individuals with ADHD to violate social norms and engage in aggressive or non-compliant actions.
Explanation: ***Chronic steroid use*** - **Glucocorticoids**, commonly used in the treatment of bronchial asthma, can directly inhibit **osteoblast activity** and promote **osteoclast activity**, leading to bone loss [1]. - They also reduce intestinal **calcium absorption** and increase **renal calcium excretion**, further disrupting calcium homeostasis and contributing to osteoporosis [1]. *Calcium malabsorption* - While **malabsorption syndromes** can cause osteoporosis, asthma itself does not directly lead to primary calcium malabsorption. - Steroids used in asthma treatment can *contribute* to reduced calcium absorption, but the primary mechanism of steroid-induced osteoporosis involves broader effects on bone metabolism, not solely malabsorption [1]. *Inflammatory mediators* - **Inflammatory mediators** associated with asthma may play a role in bone density loss, but their direct impact is less significant and less common than the effects of chronic steroid use [2]. - While chronic inflammation can indirectly affect bone remodeling, it is not the most likely or direct mechanism for osteoporosis in this clinical scenario compared to steroid exposure [1]. *Physical inactivity* - **Physical inactivity** can contribute to osteoporosis due to reduced mechanical loading on bones, but it is not a direct or primary cause specific to bronchial asthma [3]. - While severe asthma may lead to some activity limitation, the primary mechanism linking asthma treatment to osteoporosis is typically medication-related, rather than lifestyle factors alone.
Get full access to all questions, explanations, and performance tracking.
Start For Free